Marshall Wace’s NEOPHOTONICS CORP NPTN Stock Holding History

Marshall Wace’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-272,134	Closed	-$4.28M	–	4047
2022 Q2	$4.28M	Buy	272,134 +203,039	+294%	+$3.1M	0.01%	1455
2022 Q1	$1.05M	Buy	69,095 +569	+0.8%	+$8.67K	﹤0.01%	2430
2021 Q4	$1.05M	Buy	68,526 +46,878	+217%	+$617K	﹤0.01%	2448
2021 Q3	$189K	Sell	21,648 -18,137	-46%	-$165K	﹤0.01%	2813
2021 Q2	$406K	Buy	+39,785	New	+$420K	﹤0.01%	2226
2020 Q2	–	Sell	-35,002	Closed	-$254K	–	2078
2020 Q1	$254K	Buy	35,002 +25,915	+285%	+$192K	﹤0.01%	1131
2019 Q4	$80K	Buy	+9,087	New	+$68K	﹤0.01%	1491
2019 Q2	–	Sell	-15,037	Closed	-$95K	–	1997
2019 Q1	$95K	Buy	15,037 +14,740	+4,963%	+$103K	﹤0.01%	1443
2018 Q4	$2K	Buy	+297	New	+$2.27K	﹤0.01%	1554
2017 Q1	–	Sell	-56,750	Closed	-$613K	–	839
2016 Q4	$613K	Buy	+56,750	New	+$757K	﹤0.01%	822

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Marshall Wace's NPTN Position: Q3 2022 in Review

Marshall Wace sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 272,134 shares — an estimated $4.28M sold.

Marshall Wace first reported a position in NPTN in Q4 2016 and held it in 10 quarters. The position peaked at $4.28M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Marshall Wace reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Marshall Wace sold 272,134 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.28M.
Marshall Wace first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 10 quarters.
Marshall Wace's NEOPHOTONICS CORP position peaked at $4.28M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.